BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1266 related articles for article (PubMed ID: 10561373)

  • 1. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison.
    Kopp M; Schweigkofler H; Holzner B; Nachbaur D; Niederwieser D; Fleischhacker WW; Kemmler G; Sperner-Unterweger B
    Eur J Haematol; 2000 Aug; 65(2):97-103. PubMed ID: 10966168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
    Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
    Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research.
    Holzner B; Bode RK; Hahn EA; Cella D; Kopp M; Sperner-Unterweger B; Kemmler G
    Eur J Cancer; 2006 Dec; 42(18):3169-77. PubMed ID: 17045472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life measurement in oncology--a matter of the assessment instrument?
    Holzner B; Kemmler G; Sperner-Unterweger B; Kopp M; Dünser M; Margreiter R; Marschitz I; Nachbaur D; Fleischhacker WW; Greil R
    Eur J Cancer; 2001 Dec; 37(18):2349-56. PubMed ID: 11720827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of EORTC quality of life core questionnaire (EORTC-QLQ-C30) and gastrointestinal quality of life index (GIQLI) in patients undergoing elective colorectal cancer resection.
    Schwenk W; Neudecker J; Haase O; Raue W; Strohm T; Müller JM
    Int J Colorectal Dis; 2004 Nov; 19(6):554-60. PubMed ID: 15205989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy.
    Iravani K; Jafari P; Akhlaghi A; Khademi B
    Health Qual Life Outcomes; 2018 Sep; 16(1):183. PubMed ID: 30217200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two quality of life instruments for cancer patients: the Ferrans and Powers Quality of Life Index and the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire C30.
    Gupta D; Grutsch JF; Lis CG
    J Soc Integr Oncol; 2008; 6(1):13-8. PubMed ID: 18302906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires.
    Cheung YB; Goh C; Thumboo J; Khoo KS; Wee J
    J Clin Oncol; 2005 Aug; 23(22):4936-44. PubMed ID: 16051946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
    Hagiwara Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
    Health Qual Life Outcomes; 2020 Nov; 18(1):354. PubMed ID: 33143687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.
    McLachlan SA; Devins GM; Goodwin PJ
    Eur J Cancer; 1998 Mar; 34(4):510-7. PubMed ID: 9713301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. French version of FACT-G: validation and comparison with other cancer-specific instruments.
    Conroy T; Mercier M; Bonneterre J; Luporsi E; Lefebvre JL; Lapeyre M; Puyraveau M; Schraub S
    Eur J Cancer; 2004 Oct; 40(15):2243-52. PubMed ID: 15454249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating and improving the reliability of the EORTC qlq-c30 using a multidimensional Rasch model.
    Shih CL; Chen CH; Sheu CF; Lang HC; Hsieh CL
    Value Health; 2013; 16(5):848-54. PubMed ID: 23947980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.